|
Ortega-Alvarez D, Tebar-Garcia D, Casado-Pelaez M, Olivares-Osuna D, Castillo-Agea E, Balibrea-Rull J, Barbella-Aponte RA, Perez-Parra D, Musulen E, Guardia C, Vinuesa-Pitarch E, Sanchez-Lopez ME, Postigo-Corrales F, Ballana E, Martinez-Cardus A, Margeli M, Esteller M, Fernandez PL, Luengo-Gil G, Mereu E, Galan-Moya EM, Rodilla V. Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies. Cancer Res. 2026 Feb 11. doi: 10.1158/0008-5472.CAN-24-2758. Online ahead of print. PubMed PMID: 41671401.
AÑO: 2026; IF: 16.6
|
41671401
|
Rodriguez-Martinez A, Giraldo-Ruiz L, Ramos MC, Luque I, Ribeiro D, Postigo-Corrales F, Alburquerque-Gonzalez B, Montoro-Garcia S, Arroyo-Rodriguez AB, Conesa-Zamora P, Hurtado AM, Luengo-Gil G, Perez-Sanchez H. Discovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancer. Sci Rep. 2025 Apr 28;15(1):14906. doi: 10.1038/s41598-025-96457-x. PubMed PMID: 40295602; PubMed Central PMCID: PMC12037858.
AÑO: 2025; IF: 3.9
|
|
Muniz-Castrillo M, Blaya Boluda N, Garcia-Torralba E, Jimenez-Fonseca P, Gonzalez Del Rey C, Balbin M, Luengo-Gil G, Ayala de la Pena F, Esteban Gonzalez E, Carmona-Bayonas A. Dysfunctional mismatch repair in patients with early triple-negative breast cancer. Clin Transl Oncol. 2025 May 4. doi: 10.1007/s12094-025-03933-x. Online ahead of print. PubMed PMID: 40319412.
AÑO: 2025; IF: 2.5
|
|
Morva A, Arroyo AB, Andreeva L, Tapia-Abellan A, Luengo-Gil G. Unleashing the power of CAR-M therapy in solid tumors: a comprehensive review. Front Immunol. 2025 Jun 12;16:1615760. doi: 10.3389/fimmu.2025.1615760. eCollection 2025. PubMed PMID: 40574837; PubMed Central PMCID: PMC12198237.
AÑO: 2025; IF: 5.9
|
|
Feliciangeli E, Albaladejo-Gonzalez A, Garcia-Rodriguez J, Lazaro-Sanchez A, Borg R, Pimentel-Caceres P, Soriano-Polo D, Rodriguez-Braun E, Balsalobre-Yago J, Martinez-Ortiz MJ, Wikstrom-Fernandez S, Murillo-Herrera A, Garcia-Garcia T, Garcia-Solano J, Conesa-Zamora P, Luengo-Gil G. Clinical and immunopathological evaluation and its comparison with IHC consensus molecular subtypes of colorectal cancer. Sci Rep. 2025 Jul 1;15(1):21626. doi: 10.1038/s41598-025-04962-w. PubMed PMID: 40594059.
AÑO: 2025; IF: 3.9
|